Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1231125.RArUh9PL_2-Dw6q94FQxnYaanZOoStv2h10eX4gyZ-mCM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1231125.RArUh9PL_2-Dw6q94FQxnYaanZOoStv2h10eX4gyZ-mCM130_assertion type Assertion NP1231125.RArUh9PL_2-Dw6q94FQxnYaanZOoStv2h10eX4gyZ-mCM130_head.
- NP1231125.RArUh9PL_2-Dw6q94FQxnYaanZOoStv2h10eX4gyZ-mCM130_assertion description "[Among numerous EMT-associated transcripts, Smad7 is considered to be an inhibitor, however its involvement together with TGF-?1 in the progression of ovarian cancer remains to be elucidated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231125.RArUh9PL_2-Dw6q94FQxnYaanZOoStv2h10eX4gyZ-mCM130_provenance.
- NP1231125.RArUh9PL_2-Dw6q94FQxnYaanZOoStv2h10eX4gyZ-mCM130_assertion evidence source_evidence_literature NP1231125.RArUh9PL_2-Dw6q94FQxnYaanZOoStv2h10eX4gyZ-mCM130_provenance.
- NP1231125.RArUh9PL_2-Dw6q94FQxnYaanZOoStv2h10eX4gyZ-mCM130_assertion SIO_000772 25333457 NP1231125.RArUh9PL_2-Dw6q94FQxnYaanZOoStv2h10eX4gyZ-mCM130_provenance.
- NP1231125.RArUh9PL_2-Dw6q94FQxnYaanZOoStv2h10eX4gyZ-mCM130_assertion wasDerivedFrom befree-2016 NP1231125.RArUh9PL_2-Dw6q94FQxnYaanZOoStv2h10eX4gyZ-mCM130_provenance.
- NP1231125.RArUh9PL_2-Dw6q94FQxnYaanZOoStv2h10eX4gyZ-mCM130_assertion wasGeneratedBy ECO_0000203 NP1231125.RArUh9PL_2-Dw6q94FQxnYaanZOoStv2h10eX4gyZ-mCM130_provenance.